HEALTH CARE RESOURCE UTILIZATION AND ASSOCIATED COSTS AMONG LOWER-RISK MYELODYSPLASTIC SYNDROME PATIENTS IN FRANCE: EDELWEISS STUDY

被引：0

作者：

Comont, T. ^{[1
]}

Fernandes, J. ^{[2
]}

Chartier, M. ^{[3
]}

Cotte, F. E. ^{[4
]}

Pages, N. ^{[5
]}

Panes, A. ^{[5
]}

Schmidt, A. ^{[5
]}

Webert, L. ^{[3
]}

D. Aveni-Piney, M. ^{[6
]}

机构：

[1] CHU Toulouse, Toulouse, France

[2] Ctr Hosp Cote Basque, Bayonne, France

[3] Bristol Myers Squibb, Rueil Malmaison, France

[4] Bristol Myers Squibb, Rueil Malmaison 92, France

[5] HEVA, Lyon, France

[6] CHRU Nancy, Nancy, France

来源：

VALUE IN HEALTH | 2024年 / 27卷 / 12期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

SA67

引用

页码：S627 / S627

页数：1

共 50 条

[31] Health Care Resource Utilization and Costs for Patients with Tardive Dyskinesia
Carroll, Benjamin
Irwin, Debra E.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (07): : 810 - +
[32] A DESCRIPTIVE ANALYSIS OF THE HEALTH CARE UTILIZATION AND COSTS OF PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROME IN THE US MEDICARE POPULATION
Lin, Y.
Ogbomo, A.
Wang, Y.
Xie, L.
Yuce, H.
Baser, O.
VALUE IN HEALTH, 2017, 20 (05) : A130 - A131
[33] Recombinant Human Thrombopoietin Accelerates the Recovery of Platelet in Patients with Lower-Risk Myelodysplastic Syndrome: A Prospective Cohort Study
Yang, Yuan
Wang, Zhao
Han, Bing
BLOOD, 2021, 138
[34] Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study
Lee, Je-Hwan
Kim, Yoo-Jin
Sohn, Sang Kyun
Yoon, Sung-Soo
Kim, Hawk
Cheong, June-Won
Lee, Won-Sik
Lee, Gyeong-Won
Lim, Sung-Nam
Kim, Min Kyoung
Lee, Ho Sup
Kim, Hyeoung-Joon
LEUKEMIA RESEARCH, 2017, 60 : 135 - 144
[35] Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV
Dunn, Keith
Lafeuille, Marie-Helene
Jiao, Xiaolong
Romdhani, Hela
Emond, Bruno
Woodruff, Kimberly
Pesa, Jacqueline
Tandon, Neeta
Lefebvre, Patrick
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (10): : 1040 - 1051
[36] Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
Hoeks, Marlijn
Bagguley, Tim
van Marrewijk, Corine
Smith, Alex
Bowen, David
Culligan, Dominic
Kolade, Seye
Symeonidis, Argiris
Garelius, Hege
Spanoudakis, Michail
Langemeijer, Saskia
Roelofs, Rian
Wiegerinck, Erwin
Tatic, Aurelia
Killick, Sally
Panagiotidis, Panagiotis
Stanca, Oana
Hellstrom-Lindberg, Eva
Cermak, Jaroslav
van der Klauw, Melanie
Wouters, Hanneke
van Kraaij, Marian
Blijlevens, Nicole
Swinkels, Dorine W.
de Witte, Theo
LEUKEMIA, 2021, 35 (06) : 1745 - 1750
[37] Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review
Ooi, Soo Liang
Campbell, Ron
Pak, Sok Cheon
Golombick, Terry
Manoharan, Arumugam
Ramakrishna, Raj
Badmaev, Vladimir
Schloss, Janet
INTEGRATIVE CANCER THERAPIES, 2021, 20
[38] HEALTH CARE COSTS AND RESOURCE UTILIZATION FOR ACUTE CORONARY SYNDROME IN PATIENTS WITH AND WITHOUT DIABETES MELLITUS
Zhao, Z.
Zhu, B.
Anderson, J.
Bayt, T.
LeNarz, L.
VALUE IN HEALTH, 2009, 12 (07) : A326 - A327
[39] Health Care Utilization and Costs by Metabolic Syndrome Risk Factors
Boudreau, D. M.
Malone, D. C.
Raebel, M. A.
Fishman, P. A.
Nichols, G. A.
Feldstein, A. C.
Boscoe, A. N.
Ben-Joseph, R. H.
Magid, D. J.
Okamoto, L. J.
METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (04) : 305 - 313
[40] Health Care Resource Utilization by Patients with Alagille Syndrome
Ebel, Noelle H.
Goldstein, Andrea
Howard, Robin
Mogul, Douglas B.
Marden, Jessica R.
Anderson, Annika
Gaburo, Katherine
Kirson, Noam
Rosenthal, Philip
JOURNAL OF PEDIATRICS, 2023, 253 : 144 - +

← 1 2 3 4 5 →